201 related articles for article (PubMed ID: 8933765)
1. Loss and restoration of immune privilege in eyes with corneal neovascularization.
Dana MR; Streilein JW
Invest Ophthalmol Vis Sci; 1996 Nov; 37(12):2485-94. PubMed ID: 8933765
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege.
Dana MR; Dai R; Zhu S; Yamada J; Streilein JW
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):70-7. PubMed ID: 9430547
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
Yamada J; Zhu SN; Streilein JW; Dana MR
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
[TBL] [Abstract][Full Text] [Related]
4. Latanoprost does not affect immune privilege of corneal allografts.
Wang M; Kitahara Y; Yoshida A; Hori J
Exp Eye Res; 2008 Feb; 86(2):394-402. PubMed ID: 18187130
[TBL] [Abstract][Full Text] [Related]
5. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
Yamada J; Streilein JW
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
[TBL] [Abstract][Full Text] [Related]
6. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive properties of tissues obtained from eyes with experimentally manipulated corneas.
Streilein JW; Bradley D; Sano Y; Sonoda Y
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):413-24. PubMed ID: 8603847
[TBL] [Abstract][Full Text] [Related]
8. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
Wenkel H; Chen PW; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
[TBL] [Abstract][Full Text] [Related]
9. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
[TBL] [Abstract][Full Text] [Related]
10. Analysis of immune deviation elicited by antigens injected into the subretinal space.
Wenkel H; Streilein JW
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1823-34. PubMed ID: 9727405
[TBL] [Abstract][Full Text] [Related]
11. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts.
Sonoda A; Sonoda Y; Muramatu R; Streilein JW; Usui M
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):790-8. PubMed ID: 10711695
[TBL] [Abstract][Full Text] [Related]
12. Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival.
Niederkorn JY; Mayhew E; Mellon J; Hegde S
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2674-81. PubMed ID: 15277491
[TBL] [Abstract][Full Text] [Related]
13. Effects of experimental ocular inflammation on ocular immune privilege.
Ohta K; Wiggert B; Taylor AW; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2010-8. PubMed ID: 10440255
[TBL] [Abstract][Full Text] [Related]
14. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation.
Ishioka M; Okamoto S; Streilein JW; Jiang LQ
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279
[TBL] [Abstract][Full Text] [Related]
15. IL-6 antagonizes TGF-beta and abolishes immune privilege in eyes with endotoxin-induced uveitis.
Ohta K; Yamagami S; Taylor AW; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2591-9. PubMed ID: 10937571
[TBL] [Abstract][Full Text] [Related]
16. Lymphoma allografts abrogate immune privilege within the anterior chamber of the eye.
Niederkorn JY; Streilein JW
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1235-43. PubMed ID: 3089965
[TBL] [Abstract][Full Text] [Related]
17. Analysis of immune privilege in eyes with Mycobacteria tuberculosa adjuvant-induced uveitis.
Mo JS; Streilein JW
Ocul Immunol Inflamm; 2005; 13(2-3):139-47. PubMed ID: 16019673
[TBL] [Abstract][Full Text] [Related]
18. Ocular injuries following sulfur mustard exposure--pathological mechanism and potential therapy.
Kadar T; Dachir S; Cohen L; Sahar R; Fishbine E; Cohen M; Turetz J; Gutman H; Buch H; Brandeis R; Horwitz V; Solomon A; Amir A
Toxicology; 2009 Sep; 263(1):59-69. PubMed ID: 19061933
[TBL] [Abstract][Full Text] [Related]
19. Induction of donor-specific ACAID can prolong orthotopic corneal allograft survival in "high-risk" eyes.
Sano Y; Okamoto S; Streilein JW
Curr Eye Res; 1997 Nov; 16(11):1171-4. PubMed ID: 9395779
[TBL] [Abstract][Full Text] [Related]
20. [The influence of glaucoma filtration surgery on anterior chamber associated immune deviation in mice].
Xu JJ; Sun XH
Zhonghua Yan Ke Za Zhi; 2009 Jan; 45(1):32-7. PubMed ID: 19484928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
